intermune inc (ITMN:NASDAQ GS)
As of 8:10 PM 06/19/13 All times are local (Market data is delayed by at least 15 minutes).
Key Executives - intermune inc (ITMN)
| Name | Board Relationships | Title | Age |
| Daniel G. Welch | 76 Relationships | Chairman, Chief Executive Officer and President | 54 |
| John C. Hodgman B.S., M.B.A. | 6 Relationships | Chief Financial Officer, Principal Accounting Officer and Executive Vice President | 57 |
| Giacomo Di Nepi | No Relationships | Senior Vice President and Managing Director of Europe Operations | 58 |
| Markus Dieken | No Relationships | Senior Vice President and General Manager of Germany Operations | -- |
| Robert S. Fishman M.D., ‚ F.C.C.P. | 23 Relationships | Senior Vice President of Clinical Development | 50 |
Board Members - intermune inc (ITMN)
| Name | Board Relationships | Primary Company | Age |
| Daniel G. Welch | 76 Relationships | InterMune Inc. | 54 |
| David S. Kabakoff Ph.D. | 47 Relationships | Sofinnova Ventures, Inc. | 64 |
| Lars G. Ekman M.D., Ph.D. | 54 Relationships | Sophiris Bio, Inc. | 62 |
| Louis C. Drapeau B.S., M.B.A. | 39 Relationships | InSite Vision Incorporated | 68 |
| Frank A.G.M. Verwiel M.D. | 10 Relationships | Aptalis Holdings Inc. | 49 |
Executive Committees* - intermune inc (ITMN)
| Committee Name | Chairperson | Board Relationships | Members |
| Audit Committee | Louis C. Drapeau B.S., M.B.A. | 39 Relationships | 4 Executives |
| Compensation Committee | Frank A.G.M. Verwiel M.D. | 10 Relationships | 3 Executives |
| Nominating Committee | David S. Kabakoff Ph.D. | 47 Relationships | 3 Executives |
| Corporate Governance Committee | David S. Kabakoff Ph.D. | 47 Relationships | 3 Executives |
*Data is at least as current as the most recent Definitive Proxy.
| Recently Viewed | |||
| ITMN:US | $9.99 USD | +0.14 |  |
| Company | Last | Change |
| Amarillo Biosciences Inc | $0.02 USD | 0.00 |
| Biogen Idec Inc | $203.80 USD | -7.00 |
| Cell Therapeutics Inc | $1.24 USD | -0.09 |
| Hemispherx Biopharma Inc | $0.25 USD | -0.0038 |
| Roche Holding AG | SFr.230.40 CHF | +1.50 |
| View Industry Companies | ||
Industry Analysis
ITMN
Industry Average
| Valuation | ITMN | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 24.0x |
|
| Price/Book | 4.9x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 3.2x |
|
Post a JobJobs
- Chicago, IL | DunnhumbyusaPosted: Jun 18
- Thomasville, GA | Flowers FoodsPosted: Jun 07
- San Francisco, CA | YelpPosted: Jun 06
- San Francisco, CA | PeoplematterPosted: Jun 06
Sponsored Financial Commentaries
Sponsored Links
Report Data Issue
To contact INTERMUNE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Please enter your information in the following field(s):
Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
